Chronic Myelomonocytic Leukemia — Trials

Chronic Myelomonocytic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

292 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 86
Recruiting: 51
Ph III recruiting: 3
Growth YoY: —
Industry share: 19%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 25.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (43)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06071624	Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Chronic Myelomonocytic Leukemia, CMML.	suspended	Phase 1	30	Huda SalmanOTHER	1	Sep 24, 2026	clinicaltrials

Data updated 5 days agoSource updated Sep 24, 2026source: clinicaltrials